SAGE THERAPEUTICS for SAGE THERAPEUTICS
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Mental Health Innovation at large substances - Cares Act. Telehealth and controlled substance prescribing habits for serious mental illness. Extension of Public Health Emergency Act for telehealth. Senate drug pricing reforms under Medicare Part D. TRIPS Waiver. Fixes to the Inflation Reduction Act of 2022 (P.L.117-169). Mental Health Care - PPD screening guidelines in Momnibus bills (H.R.3305/S.1606).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE GARNER | — |
| MARGARET MANN | — |
Medicare/Medicaid MMM
Telehealth Medicare physician reimbursement. P.L.117-169 - Inflation Reduction Act of 2022 and potential fixes to the IRA. Maternal mental health legislation, like Momnibus (H.R.3305/S.1606).
| Lobbyist | Covered position, as disclosed |
|---|---|
| JULIE GARNER | — |
| MARGARET MANN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.